Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice

(2012) Gregory Y. H. Lip et al.   THROMBOSIS AND HAEMOSTASIS

Safety of Percutaneous Left Atrial Appendage Closure

(2011) Vivek Y. Reddy et al.   CIRCULATION

Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation

(2011) U. Landmesser et al.   EUROPEAN HEART JOURNAL

The role of aspirin for stroke prevention in atrial fibrillation

(2011) Gregory Y. H. Lip   Nature Reviews Cardiology

What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?

(2011) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

(2011) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

HOW DOES LEFT ATRIAL APPENDAGE OCCLUSION USING THE WATCHMAN DEVICE COMPARE TO DABIGATRAN FOR REDUCING THROMBOEMBOLIC EVENTS IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION?

(2010) Sanjay Kaul et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Left Atrial Appendage Occlusion Does Not Eliminate the Need for Warfarin

(2009) Richard P. Whitlock et al.   CIRCULATION

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

(2009) David R Holmes et al.   LANCET